U.S. Army awards Moderna $3.3B contract for 200 million more vaccines

Vials of the Moderna COVID-19 vaccine.
Vials of the Moderna COVID-19 vaccine. Photo credit Yuichi Yamazaki/Getty Images

Moderna has secured a contract with the U.S. Army to provide an additional 200 million doses of the pharmaceutical company’s COVID-19 vaccine.

The Department of Defense announced the deal worth $3.3 billion Monday. The new contract brings the federal government’s total order of vaccines to 500 million doses.

Moderna will produce the vaccines stateside at its biotech facility in Cambridge, Massachusetts. The new shots should be delivered in full by the end of March 2022. Officials anticipate more than half of those doses will arrive within the last three months of this year.

The contract -- awarded just one week ago using Army funds for research, development, and testing -- includes an option for the government to buy more vaccines if needed.

So far, Moderna has delivered 217 million COVID-19 vaccines to the U.S.